Indivior Stock

Indivior ROE 2024

Indivior ROE

0

Ticker

INDV.L

ISIN

GB00BRS65X63

WKN

A12FHW

In 2024, Indivior's return on equity (ROE) was 0, a -100% increase from the -1.04 ROE in the previous year.

Indivior Aktienanalyse

What does Indivior do?

Indivior PLC is a globally operating company that specializes in the development and marketing of therapies for the treatment of addiction disorders. The company is headquartered in Slough, UK, and employs around 900 people worldwide. Indivior's history dates back to the founding of Reckitt Benckiser Pharmaceuticals in 1994. However, in 2014, the company decided to spin off its pharmaceutical division and continue as an independent company. Since then, Indivior has continuously invested in research and development to develop new and innovative therapies for the treatment of opioid addiction and other addiction disorders. Indivior's business model is based on ensuring comprehensive patient care for those suffering from addiction disorders through close collaboration with health authorities, doctors, and other healthcare professionals. The company relies on a combination of medical therapies and psychosocial support. Indivior operates in various divisions that focus on different aspects of addiction treatment. The key divisions are: - Opioid addiction: Indivior offers various therapies for the treatment of opioid addiction, including Suboxone Film and Sublocade, both based on buprenorphine. - Alcohol addiction: Indivior has also developed a therapy for the treatment of alcohol addiction marketed under the name ALO-02. - Pain therapy: Indivior has also developed a range of pain therapies based on buprenorphine or naloxone. - Research and development: A major focus of Indivior is on researching and developing new therapies for the treatment of addiction disorders. Indivior has also formed partnerships with other companies and organizations in the healthcare industry to improve the care of patients with addiction disorders. This includes collaboration with patient organizations advocating for the interests of patients with addiction disorders. Overall, Indivior has achieved impressive success in developing innovative therapies for the treatment of addiction disorders in recent years. The company has not only strengthened its position as a leading provider of opioid therapies, but also made progress in other areas such as alcohol addiction and pain therapy. However, Indivior has also faced challenges. For example, the company had to address allegations related to the marketing of Suboxone Film and other products. However, Indivior has taken steps to improve its compliance procedures and ensure that its products are marketed in accordance with applicable regulations. Overall, Indivior remains a leading provider of therapies for the treatment of addiction disorders and is committed to improving the quality of life for patients with addiction problems. Indivior ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Indivior's Return on Equity (ROE)

Indivior's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Indivior's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Indivior's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Indivior’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Indivior stock

What is the ROE (Return on Equity) of Indivior this year?

The ROE of Indivior this year is 0 undefined.

How has the Return on Equity (ROE) of Indivior developed compared to the previous year?

The ROE of Indivior has increased by -100% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Indivior?

A high ROE indicates that Indivior generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Indivior?

A low ROE can indicate that Indivior is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Indivior affect the company?

A change in ROE (Return on Equity) of Indivior can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Indivior?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Indivior?

Some factors that can influence Indivior's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Indivior pay?

Over the past 12 months, Indivior paid a dividend of 0.07 USD . This corresponds to a dividend yield of about 0.58 %. For the coming 12 months, Indivior is expected to pay a dividend of 0.59 USD.

What is the dividend yield of Indivior?

The current dividend yield of Indivior is 0.58 %.

When does Indivior pay dividends?

Indivior pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Indivior?

Indivior paid dividends every year for the past 5 years.

What is the dividend of Indivior?

For the upcoming 12 months, dividends amounting to 0.59 USD are expected. This corresponds to a dividend yield of 4.69 %.

In which sector is Indivior located?

Indivior is assigned to the 'Health' sector.

Wann musste ich die Aktien von Indivior kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Indivior from 7/29/2016 amounting to 0.073 USD, you needed to have the stock in your portfolio before the ex-date on 6/16/2016.

When did Indivior pay the last dividend?

The last dividend was paid out on 7/29/2016.

What was the dividend of Indivior in the year 2023?

In the year 2023, Indivior distributed 0 USD as dividends.

In which currency does Indivior pay out the dividend?

The dividends of Indivior are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Indivior stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Indivior

Our stock analysis for Indivior Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Indivior Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.